Literature DB >> 18249219

Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study.

Tuomas O Kilpeläinen1, Timo A Lakka, David E Laaksonen, Ursula Mager, Titta Salopuro, Agata Kubaszek, Boryana Todorova, Olli Laukkanen, Jaana Lindström, Johan G Eriksson, Helena Hämäläinen, Sirkka Aunola, Pirjo Ilanne-Parikka, Sirkka Keinänen-Kiukaanniemi, Jaako Tuomilehto, Markku Laakso, Matti Uusitupa.   

Abstract

Single nucleotide polymorphisms (SNPs) in the ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL genes were associated with the conversion from impaired glucose tolerance (IGT) to type 2 diabetes mellitus (T2D) in the Finnish Diabetes Prevention Study (DPS). In this study, we determined whether polymorphisms in these genes modified the effect of changes in physical activity (PA) on the risk of T2D in the DPS. Moreover, we assessed whether the polymorphisms modified the effect of changes in PA on changes in measures of body fat, serum lipids, and blood pressure during the first year of the follow-up of the DPS. Overweight subjects with IGT (n = 487) were followed for an average of 4.1 years, and PA was assessed annually with a questionnaire. The interactions of the polymorphisms with changes in total and moderate-to-vigorous PA on the conversion to T2D during the 4.1-year follow-up were assessed using Cox regression with adjustments for the other components of the intervention (dietary changes, weight reduction). Univariate analysis of variance was used to assess interactions on changes in continuous variables during the first year of the follow-up. No interaction between the polymorphisms and PA on the conversion to T2D was found. The Leu72Met (rs696217) polymorphism in GHRL modified the effect of moderate-to-vigorous PA on changes in weight and waist circumference, the -501A/C (rs26802) polymorphism in GHRL modified the effect of total and moderate-to-vigorous PA on change in high-density lipoprotein cholesterol, and the Lys109Arg (rs1137100) polymorphism in LEPR modified the effect of total PA on change in blood pressure. In conclusion, genetic variation may modify the magnitude of the beneficial effects of PA on characteristics of the metabolic syndrome in persons with IGT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18249219     DOI: 10.1016/j.metabol.2007.10.022

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  14 in total

1.  No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels.

Authors:  Robert A Scott; Audrey Y Chu; Niels Grarup; Alisa K Manning; Marie-France Hivert; Dmitry Shungin; Anke Tönjes; Ajay Yesupriya; Daniel Barnes; Nabila Bouatia-Naji; Nicole L Glazer; Anne U Jackson; Zoltán Kutalik; Vasiliki Lagou; Diana Marek; Laura J Rasmussen-Torvik; Heather M Stringham; Toshiko Tanaka; Mette Aadahl; Dan E Arking; Sven Bergmann; Eric Boerwinkle; Lori L Bonnycastle; Stefan R Bornstein; Eric Brunner; Suzannah J Bumpstead; Soren Brage; Olga D Carlson; Han Chen; Yii-Der Ida Chen; Peter S Chines; Francis S Collins; David J Couper; Elaine M Dennison; Nicole F Dowling; Josephine S Egan; Ulf Ekelund; Michael R Erdos; Nita G Forouhi; Caroline S Fox; Mark O Goodarzi; Jürgen Grässler; Stefan Gustafsson; Göran Hallmans; Torben Hansen; Aroon Hingorani; John W Holloway; Frank B Hu; Bo Isomaa; Karen A Jameson; Ingegerd Johansson; Anna Jonsson; Torben Jørgensen; Mika Kivimaki; Peter Kovacs; Meena Kumari; Johanna Kuusisto; Markku Laakso; Cécile Lecoeur; Claire Lévy-Marchal; Guo Li; Ruth J F Loos; Valeri Lyssenko; Michael Marmot; Pedro Marques-Vidal; Mario A Morken; Gabriele Müller; Kari E North; James S Pankow; Felicity Payne; Inga Prokopenko; Bruce M Psaty; Frida Renström; Ken Rice; Jerome I Rotter; Denis Rybin; Camilla H Sandholt; Avan A Sayer; Peter Shrader; Peter E H Schwarz; David S Siscovick; Alena Stancáková; Michael Stumvoll; Tanya M Teslovich; Gérard Waeber; Gordon H Williams; Daniel R Witte; Andrew R Wood; Weijia Xie; Michael Boehnke; Cyrus Cooper; Luigi Ferrucci; Philippe Froguel; Leif Groop; W H Linda Kao; Peter Vollenweider; Mark Walker; Richard M Watanabe; Oluf Pedersen; James B Meigs; Erik Ingelsson; Inês Barroso; Jose C Florez; Paul W Franks; Josée Dupuis; Nicholas J Wareham; Claudia Langenberg
Journal:  Diabetes       Date:  2012-03-13       Impact factor: 9.461

2.  Highlights from the functional single nucleotide polymorphisms associated with human muscle size and strength or FAMuSS study.

Authors:  Linda S Pescatello; Joseph M Devaney; Monica J Hubal; Paul D Thompson; Eric P Hoffman
Journal:  Biomed Res Int       Date:  2013-12-23       Impact factor: 3.411

Review 3.  Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review.

Authors:  Xiao-Lin Li; Jian-Qing Sui; Lin-Lin Lu; Nan-Nan Zhang; Xin Xu; Quan-Yong Dong; Yong-Ning Xin; Shi-Ying Xuan
Journal:  Lipids Health Dis       Date:  2016-03-10       Impact factor: 3.876

Review 4.  Lifestyle precision medicine: the next generation in type 2 diabetes prevention?

Authors:  Pascal M Mutie; Giuseppe N Giordano; Paul W Franks
Journal:  BMC Med       Date:  2017-09-22       Impact factor: 8.775

5.  Association of two synonymous splicing-associated CpG single nucleotide polymorphisms in calpain 10 and solute carrier family 2 member 2 with type 2 diabetes.

Authors:  Maria Karambataki; Andigoni Malousi; Georgios Tzimagiorgis; Constantinos Haitoglou; Aikaterini Fragou; Elisavet Georgiou; Foteini Papadopoulou; Gerasimos E Krassas; Sofia Kouidou
Journal:  Biomed Rep       Date:  2016-12-29

6.  A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer.

Authors:  Yueyao Du; Tingting Yan; Liheng Zhou; Wenjin Yin; Jinsong Lu
Journal:  Breast Cancer (Dove Med Press)       Date:  2018-11-27

7.  Multivariate analysis of genomics data to identify potential pleiotropic genes for type 2 diabetes, obesity and dyslipidemia using Meta-CCA and gene-based approach.

Authors:  Yuan-Cheng Chen; Chao Xu; Ji-Gang Zhang; Chun-Ping Zeng; Xia-Fang Wang; Rou Zhou; Xu Lin; Zeng-Xin Ao; Jun-Min Lu; Jie Shen; Hong-Wen Deng
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

8.  Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program.

Authors:  Toni I Pollin; Tamara Isakova; Kathleen A Jablonski; Paul I W de Bakker; Andrew Taylor; Jarred McAteer; Qing Pan; Edward S Horton; Linda M Delahanty; David Altshuler; Alan R Shuldiner; Ronald B Goldberg; Jose C Florez; Paul W Franks
Journal:  PLoS Genet       Date:  2012-08-30       Impact factor: 5.917

9.  Effects of lifestyle intervention on weight and metabolic parameters in patients with impaired glucose tolerance related to beta-3 adrenergic receptor gene polymorphism Trp64Arg(C/T): Results from the Japan Diabetes Prevention Program.

Authors:  Naoki Sakane; Juichi Sato; Kazuyo Tsushita; Satoru Tsujii; Kazuhiko Kotani; Makoto Tominaga; Shoji Kawazu; Yuzo Sato; Takeshi Usui; Isao Kamae; Toshihide Yoshida; Yutaka Kiyohara; Shigeaki Sato; Kokoro Tsuzaki; Kaoru Takahashi; Hideshi Kuzuya
Journal:  J Diabetes Investig       Date:  2015-10-29       Impact factor: 4.232

10.  Non-Synonymous Single-Nucleotide Polymorphisms and Physical Activity Interactions on Adiposity Parameters in Malaysian Adolescents.

Authors:  Nur Lisa Zaharan; Nor Hanisah Muhamad; Muhammad Yazid Jalaludin; Tin Tin Su; Zahurin Mohamed; M N A Mohamed; Hazreen A Majid
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-27       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.